Fig. 5From: Semaphorin 3 C enhances putative cancer stemness and accelerates peritoneal dissemination in pancreatic cancerPreclinical trial to confirm GnP efficacy using the orthotopic transplantation mouse model. (A) The experimental design of the randomized trial (untreated group / GnP group; gemcitabine (GEM, 120 mg/kg) and nab-paclitaxel (nab-PTX, 120 mg/kg)) in the orthotopic transplantation model injected with control- and SEMA3C shRNA-transduced PKCY cells. (B) Paraffin-embedded orthotopic tumor tissues were sectioned and stained with H&E. (C) The indicated excised tumor of the orthotopic model. (D) Pancreatic tumor volumes are represented as box-plot histograms. Each volume represents the mean ± SEM. (E) Waterfall plot indicating changes in the volume compared with the baseline (mean tumor volume of each no treated group). (F) Image of a mouse with malignant ascites just before euthanasia. (G) The frequency of malignant ascites in mice just before sacrificeBack to article page